Sama and colleagues conducted a recent study, published in the European Heart Journal, which concluded that men have higher concentrations of angiotensin-converting enzyme (ACE) 2 in their blood in comparison to women and that ACE2 concentrations in heart failure patients are not affected by typically used ACE inhibitors, anti-hypertensives, and angiotensin receptor blockers (ARBs).
Findings from the study led to assumptions that higher levels of ACE2 in men could explain why they appear more vulnerable to Covid-19 than women, as the SARS-CoV-2 virus has been proven to bind to the ACE2 receptor when infecting cells. Read more here.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
